Salvador Arias-Santiago

52PUBLICATIONS
97CO-AUTHORS
Nanotoxicology, health and safetyCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Environmental epidemiologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (52)

|May 27, 2026
Real-World Effectiveness and Safety of Tildrakizumab in a Large Spanish Multicenter Cohort from Spanish Psoriasis Group (GPS).

|Dec 30, 2025
Patients' Emotional Experiences and Life Changes Following a Diagnosis of Skin Cancer: A Qualitative Study Comparing Melanoma and Squamous Cell Carcinoma.

Pablo Díaz-Calvillo, Alberto Soto-Moreno, Clara Ureña-Paniego

|Nov 26, 2025
Transitioning from Cyclosporine to Tralokinumab in Moderate-to-Severe Atopic Dermatitis: A Prospective Real-World Comparison of Direct Switch vs. Short Overlap.

Clara Ureña-Paniego, Raquel Sanabria-de la Torre, Salvador Arias-Santiago

|Nov 26, 2025
Update on the Research of an Emulgel for the Effective Treatment of Atopic Dermatitis: Clinical Investigation in Children.

Almudena Gómez-Farto, Ana Leticia Jiménez-Escobar, Noelia Pérez-González

|Oct 29, 2025
Defining a Therapeutic Window of Opportunity in Alopecia Areata: Predictors of Early Response to Baricitinib.

Daniel Muñoz-Barba, Carmen García-Moronta, Alberto Soto-Moreno

|Oct 07, 2025
The Impact of Cutaneous Lupus Erythematosus on Major Life-Changing Decisions: A Cross-Sectional Study.

Daniel Muñoz-Barba, Lucía Martínez-Guillén, María de la Sierra Girón-Prieto

Pageof 9

Frequent Collaborators

22 joint publications

Trinidad Montero-Vilchez

16 joint publications

Molina-Leyva Alejandro

13 joint publications

Sánchez-Díaz Manuel

9 joint publications

Raquel Sanabria-De-la-Torre